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RESEARCH ARTICLE
Abstract Recent longitudinal neuroimaging studies in patients with electroconvulsive therapy
(ECT) suggest local effects of electric stimulation (lateralized) occur in tandem with global seizure
activity (generalized). We used electric field (EF) modeling in 151 ECT treated patients with
depression to determine the regional relationships between EF, unbiased longitudinal volume
change, and antidepressant response across 85 brain regions. The majority of regional volumes
increased significantly, and volumetric changes correlated with regional electric field (t = 3.77, df =
83, r = 0.38, p=0.0003). After controlling for nuisance variables (age, treatment number, and study
site), we identified two regions (left amygdala and left hippocampus) with a strong relationship
between EF and volume change (FDR corrected p<0.01). However, neither structural volume
changes nor electric field was associated with antidepressant response. In summary, we showed
that high electrical fields are strongly associated with robust volume changes in a dose-dependent
fashion.
Introduction
Electroconvulsive therapy (ECT) remains the most effective approach for treatment resistant depres-
sive episodes, as well as the most established neuromodulation technique (UK ECT Review Group,
2003; Fink and Taylor, 2007). Despite intensive research, however, the mechanism of action for
ECT remains unknown, but does involve at least two potentially therapeutic components: electric
perturbation and/or seizure activity. One common element across various neuromodulation techni-
ques is the application of different intensities of electric field (EF) on the human brain. Understand-
ing how ECT-induced EF interacts with the cortex and subcortical structures can both advance our
mechanistic understanding of ECT and enrich our understanding of other neuromodulation
approaches such as magnetic seizure therapy (MST), transcranial magnetic stimulation (TMS), trans-
cranial direct current stimulation (tDCS), and deep brain stimulation (DBS).
A recent longitudinal ECT-imaging study from the Global ECT-MRI Collaboration (GEMRIC)
(Oltedal et al., 2018) assessed hippocampal volume changes in a large cohort of subjects (N = 268)
receiving right unilateral (RUL) or bilateral (BL) electrode placements. The results demonstrated that
the volume of the hippocampus increased over the course of ECT treatment and correlated with the
number of ECT sessions administered during the ECT series. In addition, the subjects receiving RUL
electrode placement had a significantly larger volume change ipsilateral to the side of stimulation,
consistent with previous ECT-neuroimaging observations (Abbott et al., 2014; Dukart et al., 2014;
Pirnia et al., 2016; Bouckaert et al., 2016; Sartorius et al., 2016; Cano et al., 2018). Our most
recent study of 331 subjects with longitudinal MRI scanning pre- and post-ECT showed brain volume
increases across several subcortical and cortical regions with strong lateralization of the effects if the
electrode placement was RUL (Ousdal et al., 2019). Contrary to a priori expectations (Joshi et al.,
2016; Cano et al., 2017), increased volume in these key areas did not translate to better clinical out-
come. While the association between the number of ECT sessions and volume change and the later-
ality of the volume changes all implied a dose–response causative relationship, the role of ECT-
mediated neuroplasticity and the underlying mechanism for antidepressant response remains elu-
sive. Furthermore, given the naturalistic design of the studies included for mega-analysis (e.g., non-
responders had a longer ECT course and were frequently switched to bilateral treatment at varying
intervals), both the number of ECT sessions and electrode placement varied depending on the clini-
cal response, further confounding the dose-response association and its interpretation.
Recent research has challenged the notion that a primary purpose of electric stimulation in treat-
ing depression is to generate widespread seizure activity (Sackeim, 2015; Regenold et al., 2015).
Alternatively, electric stimulation may be a therapeutic component of ECT and similar to other non-
convulsive neuromodulation treatments. Finite-element simulation was developed to estimate the
spatial distribution of the electric field on a voxel-wise basis (Lee et al., 2012; Bikson et al., 2012).
The technique was recently validated in humans (Huang et al., 2017). Preliminary computational
analyses based on three realistic head models suggested that the ECT electric field distribution had
a direct association with clinical and cognitive outcomes, explaining the rationale behind different
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electrode placement strategies in ECT treatment (Bai et al., 2017). This finding is in agreement with
our previous observation where RUL treatment induced higher volumetric changes in the right hip-
pocampus compared to the left (Oltedal et al., 2018), implying that more lateralized electric stimu-
lation rather than a global generalized seizure, may be responsible at least for part of the
antidepressant effects of ECT. However, to date, no study has demonstrated the relationship
between ECT electric field distribution and treatment response. In this study, we used the large
Global ECT-MRI Research Collaboration (GEMRIC) ECT-imaging data set to explicitly determine the
relationships between regional 1) electric field strength and volume changes, 2) volume changes and
antidepressant response, and 3) electric field and antidepressant response. For the purpose of our
primary research question and in contrast to previous GEMRIC investigations, we limited the analy-
ses to subjects that only received right unilateral electrode placement.
Results
Clinical results
Subjects showed an average MADRS improvement of 61.3%±33.9% following ECT (pre-ECT MADRS
33.9 (range: 14–54), post-ECT MADRS 12.9 (range: 0–51). Highly significant correlations between
age and clinical response (t = 5.75, df = 149, r = 0.43, p<10 7, older patients responded better), as
well as age and total brain volume (t =  7.32, df = 149, r =  0.51, p<10 10) were also observed.
Laterality of electric field and volume change
ECT was associated with increased volume across all brain regions except the brain stem and bilat-
eral cerebellum cortex (Supplementary file 1). In the majority of the regions, right hemisphere
regions had greater volumetric change with respect to the corresponding left hemisphere region; no
left hemipshere regions had greater volumetric changes compared to the corresponding right-sided
region (Supplementary file 2, Figure 1). Average EF strongly correlated with DVol across the ROIs
(Figure 1, t = 3.77, df = 83, r = 0.38, p=0.0003). To show that this correlation was not simply due to
a general effect of the hemisphere (right side had higher EF and volume change while left side had
lower values), we calculated laterality indices in both EF and volume change. The correlation
eLife digest Electroconvulsive therapy, or ECT for short, can be an effective treatment for
severe depression. Many patients who do not respond to medication find that their symptoms
improve after ECT. During an ECT session, the patient is placed under general anesthesia and two
electrodes are attached to the scalp to produce an electric field that generates currents within the
brain. These currents activate neurons and make them fire, causing a seizure, but it remains unclear
how this reduces symptoms of depression.
For many years, researchers thought that the induced seizure must be key to the beneficial
effects of ECT, but recent studies have cast doubt on this idea. They show that increasing the
strength of the electric field alters the clinical effects of ECT, without affecting the seizure. This
suggests that the benefits of ECT depend on the electric field itself.
Argyelan et al. now show that electric fields affect the brain by making a part of the brain known
as the gray matter expand. In a large multinational study, 151 patients with severe depression
underwent brain scans before and after a course of ECT. The scans revealed that the gray matter of
the patients’ brains expanded during the treatment. The patients who experienced the strongest
electric fields showed the largest increase in brain volume, and individual brain areas expanded if
the electric field within them exceeded a certain threshold. This effect was particularly striking in two
areas, the hippocampus and the amygdala. Both of these areas are critical for mood and memory.
Further studies are needed to determine why the brain expands after ECT, and how long the
effect lasts. Another puzzle is why the improvements in depression that the patients reported after
their treatment did not correlate with changes in brain volume. Disentangling the relationships
between ECT, brain volume and depression will ultimately help develop more robust treatments for
this disabling condition.
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between laterality indices for EF and DVol also had a positive relationship (Figure 2, t = 2.13,
df = 40, r = 0.32, p=0.04) across 42 regions (brain stem is missing, since it is not a bilateral
structure).
Electric field and volume change
In a multiple regression analysis controlled for age, number of ECT sessions and site, we found that
left hippocampus and left amygdala had a strong relationship with EF in these regions (FDR cor-
rected p<0.01, Table 1). Post hoc analyses of the hippocampus (Figure 3) and amygdala (Figure 4)
illustrate that the relationship between EF and DVol was dose-dependent and scaled across the
hemispheres (hippocampus: t = 5.97, df = 300, r = 0.3259, p<0.0001; amygdala: t = 11.3538,
df = 300, r = 0.5482, p<0.0001). Age was a necessary covariate since it was a confound in our model:
both the spatial distribution of EF and volume changes correlate with age (Deng et al., 2015). We
add number of ECT as a covariate to the model to be able to compare the relative influence of EF
and number of ECT on volume change. In both left hippocampus and amygdala the effect size of EF
was the largest (hippocampus: tEF = 4.5, tAge =  2.7, tECTnum = 3.3, amygdala: tEF = 3.9,
tAge =  1.1, tECTnum = 2.1; Table 1).
We also investigated the spatial specificity of these correlations. First, we permutated the
regional labels in the volumetric changes across all possible ROIs and calculated the correlations
between the EF and DVol. The correlation between EF and the corresponding DVol (Figure 3—fig-
ure supplement 1, Figure 4—figure supplement 1, left panels, indicated with red dot) was always
in the top 5% among all possible correlations. Second, we permutated the region labels in the EF
across all possible ROIs and calculated the correlations between the EF and DVol (Figure 3—figure
Figure 1. Electric Field (EF) and volume change across 85 brain regions. Upper panel first row: Mean EF across 85 brain regions; second row: the effect
size of volume changes between baseline and at the end of the course of ECT across 85 regions. Lower panel, left: Effect sizes of right unilateral
stimulations were consistently higher on the right side than on the left side. Lower panel, right: Scatter plot of regional EF versus regional volume
change (r = 0.38; p <0.001; df = 83; t = 3.77). (d) = Cohen’s d effect size..
The online version of this article includes the following source data for figure 1:
Source data 1. Mean electric field and volume change in 85 brain regions.
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supplement 1, Figure 4—figure supplement 1 right panels). Overall these results indicate a strong
spatial selectivity in the relationship between EF and DVol.
Electric field, volume change, and clinical response
We further investigated if EF directly or indirectly (mediated via volume change) leads to clinical
response. In a multiple regression analysis, we tested if volumetric changes controlled for age, num-
ber of ECT sessions, and site had an effect on clinical response measured by MADRS changes.
Results indicated that none of the volume changes across the 85 ROIs had a significant relationship
with clinical response (Supplementary file 3, hippocampus: t
DVOL = 0.2, tAge = 5.4, tECTnum =  2.7,
amygdala: t
DVOL = 0.1, tAge = 5.6, tECTnum =  3.0). These results therefore contradicted the hypothe-
sis that EF by increasing brain volume indirectly exerts its effect on clinical response, given the nega-
tive results between the volume change (mediator) and MADRS change (outcome). Testing the
direct effect of the EF, we failed to find significant correlations between EF and clinical response
(Supplementary file 4, hippocampus: tEF = 1.2, tAge = 5.7, tECTnum =  3.0, amygdala: tEF = 1.1,
tAge = 5.7, tECTnum =  3.0). Similar to earlier studies, age strongly correlated with both clinical
response (Haq et al., 2015; O’Connor et al., 2001), also see Clinical Results) and EF distribution
(Deng et al., 2015), therefore we controlled for age in our model. The rationale for including the
number of ECT treatments as covariate needs more explanation. Due to the naturalistic nature of
the design, where most sites followed the patient until response or site-determined criteria for ECT
discontinuation, we observed a negative relationship between clinical response and the number of
ECT treatments. Not controlling for this variable could lead to spurious correlation between volume
change and clinical response (for more on this see Oltedal et al., 2018). In a post-hoc analysis, we
also examined the interaction between EF and volume change in relation to clinical outcome (exclud-
ing age as a covariate), but we again failed to find significant effects for any region. To explore fur-
ther, we investigated if changing age to baseline volume in the mixed model would modify results,
Figure 2. Laterality differences in EF and Dvol (upper panel) as well as the relationship between laterality between
EF/Dvol (lower panel). Regression line indicates the correlation between laterality indices of EF and volume change
(r = 0.32; p<0.05; df = 40; t = 2.13).
The online version of this article includes the following source data for figure 2:
Source data 1. Mean electric field and volume change asymteries in corresponding 42 brain regions.
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Table 1. The relationship between volume changes and EF across individuals (D Vol ~ EF + Age + ECTnum).
roi tEF pEF tAge tECTnum BH
EF
FDR
1 D VOLLeft.Cerebellum.Cortex  0.3668 0.7143  0.1150 1.9368 0.8205
2 D VOLLeft.Thalamus.Proper 0.0244 0.9805  0.4046 2.8696 0.9952
3 D VOLLeft.Caudate 0.6555 0.5132  0.8301 2.6428 0.6924
4 D VOLLeft.Putamen 0.5737 0.5671  0.5992 1.3203 0.7212
5 D VOLLeft.Pallidum 0.0060 0.9952 0.1026 1.2295 0.9952
6 D VOLBrain.Stem 1.2114 0.2278 0.8536 1.2309 0.4466
7 D VOLLeft.Hippocampus 4.5102 0.0000  2.6814 3.3221 0.0012
8 D VOLLeft.Amygdala 3.9069 0.0001  1.0572 2.1018 0.0061
9 D VOLLeft.Accumbens.area 2.0238 0.0449  3.4456 1.7246 0.1737
10 D VOLLeft.VentralDC 0.1740 0.8621 0.0605 2.2614 0.9395
11 D VOLRight.Cerebellum.Cortex  0.5564 0.5788 0.0677 1.3212 0.7235
12 D VOLRight.Thalamus.Proper 0.4582 0.6475 0.3541 4.0787 0.7712
13 D VOLRight.Caudate 1.2293 0.2210 1.0254 1.5097 0.4466
14 D VOLRight.Putamen 1.0724 0.2854  0.5112 1.4987 0.4756
15 D VOLRight.Pallidum 0.6045 0.5465 0.8016 2.9589 0.7181
16 D VOLRight.Hippocampus 1.5090 0.1336  1.2924 3.2473 0.3441
17 D VOLRight.Amygdala 2.9945 0.0032  0.6087 4.2603 0.0344
18 D VOLRight.Accumbens.area 1.9563 0.0524  0.8782 3.5228 0.1937
19 D VOLRight.VentralDC 0.3488 0.7278 0.5197 0.7438 0.8248
20 D VOLctx.lh.bankssts 1.1757 0.2417  0.4102 2.5801 0.4466
21 D VOLctx.lh.caudalanteriorcingulate 1.3404 0.1823  1.2881 2.2330 0.4254
22 D VOLctx.lh.caudalmiddlefrontal  1.8989 0.0596  0.3804 2.0087 0.2112
23 D VOLctx.lh.cuneus 0.9827 0.3274 0.1037 2.0348 0.5352
24 D VOLctx.lh.entorhinal 3.2229 0.0016  1.2447 1.6659 0.0335
25 D VOLctx.lh.fusiform 3.0717 0.0026  0.1806 2.1319 0.0344
26 D VOLctx.lh.inferiorparietal 1.5131 0.1325 0.8515 2.3077 0.3441
27 D VOLctx.lh.inferiortemporal 2.6985 0.0078 0.6415 1.9131 0.0577
28 D VOLctx.lh.isthmuscingulate  0.3275 0.7438  0.4344 2.9060 0.8319
29 D VOLctx.lh.lateraloccipital 1.1916 0.2354 0.3669 1.2752 0.4466
30 D VOLctx.lh.lateralorbitofrontal 1.4274 0.1557  0.0081 1.5758 0.3780
31 D VOLctx.lh.lingual 0.1391 0.8896 0.3506 2.4745 0.9572
32 D VOLctx.lh.medialorbitofrontal 1.0744 0.2845  0.1246 1.1852 0.4756
33 D VOLctx.lh.middletemporal 2.0679 0.0405  0.3780 2.2600 0.1720
34 D VOLctx.lh.parahippocampal 1.2683 0.2068  0.2446 2.8373 0.4466
35 D VOLctx.lh.paracentral  2.0829 0.0391 0.2511 4.0937 0.1720
36 D VOLctx.lh.parsopercularis  0.6949 0.4883  0.7822 1.8435 0.6694
37 D VOLctx.lh.parsorbitalis 0.8057 0.4218  1.0427 0.9524 0.6289
38 D VOLctx.lh.parstriangularis 0.8228 0.4120  1.2157 2.7977 0.6254
39 D VOLctx.lh.pericalcarine 0.4426 0.6587  0.0479 1.8463 0.7712
40 D VOLctx.lh.postcentral 0.8692 0.3862  1.7655 2.5145 0.5969
41 D VOLctx.lh.posteriorcingulate  0.8698 0.3859  0.6961 3.3193 0.5969
42 D VOLctx.lh.precentral  0.7279 0.4679  1.2884 2.4234 0.6682
43 D VOLctx.lh.precuneus  1.5879 0.1145  0.4353 3.6729 0.3441
44 D VOLctx.lh.rostralanteriorcingulate 1.3315 0.1852  0.4449 0.5630 0.4254
Table 1 continued on next page
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Table 1 continued
roi tEF pEF tAge tECTnum BH
EF
FDR
45 D VOLctx.lh.rostralmiddlefrontal  0.7192 0.4732  1.6205 1.1936 0.6682
46 D VOLctx.lh.superiorfrontal  1.2073 0.2293  0.5851 2.1065 0.4466
47 D VOLctx.lh.superiorparietal  1.7423 0.0836 0.6952 3.3288 0.2734
48 D VOLctx.lh.superiortemporal 2.2820 0.0240  2.0868 1.6393 0.1199
49 D VOLctx.lh.supramarginal 0.5717 0.5685  0.2467 2.1282 0.7212
50 D VOLctx.lh.frontalpole  0.2029 0.8395  0.2904 0.4776 0.9267
51 D VOLctx.lh.temporalpole 2.5288 0.0125  0.0731 1.3167 0.0762
52 D VOLctx.lh.transversetemporal 0.4387 0.6616  0.4617 2.1817 0.7712
53 D VOLctx.rh.bankssts 0.1121 0.9109 2.0777 2.9991 0.9678
54 D VOLctx.rh.caudalanteriorcingulate  1.4295 0.1551 1.2935 2.4016 0.3780
55 D VOLctx.rh.caudalmiddlefrontal  2.9569 0.0036 1.6943 2.6065 0.0344
56 D VOLctx.rh.cuneus  0.0087 0.9930  1.1806 2.4017 0.9952
57 D VOLctx.rh.entorhinal 1.2514 0.2129 0.7897 2.4722 0.4466
58 D VOLctx.rh.fusiform 1.5380 0.1263 0.7997 4.7854 0.3441
59 D VOLctx.rh.inferiorparietal  2.9902 0.0033 1.6520 0.7114 0.0344
60 D VOLctx.rh.inferiortemporal 0.9300 0.3540 1.9310 3.3455 0.5677
61 D VOLctx.rh.isthmuscingulate 0.0325 0.9741 0.4230 1.1493 0.9952
62 D VOLctx.rh.lateraloccipital 1.1796 0.2401 0.6095 1.5161 0.4466
63 D VOLctx.rh.lateralorbitofrontal 0.5347 0.5937 0.3393 2.9240 0.7314
64 D VOLctx.rh.lingual  0.0753 0.9401  1.9555 3.5258 0.9865
65 D VOLctx.rh.medialorbitofrontal 0.7090 0.4795 1.5479 2.3419 0.6682
66 D VOLctx.rh.middletemporal  0.6005 0.5492 2.1275 3.6781 0.7181
67 D VOLctx.rh.parahippocampal 1.5217 0.1303 0.5057 3.1874 0.3441
68 D VOLctx.rh.paracentral  3.5101 0.0006 2.1809 2.2718 0.0170
69 D VOLctx.rh.parsopercularis  2.5585 0.0116 2.8854 2.9459 0.0756
70 D VOLctx.rh.parsorbitalis 1.0872 0.2788  0.5812 2.3737 0.4756
71 D VOLctx.rh.parstriangularis  1.2468 0.2146 1.0686 2.6086 0.4466
72 D VOLctx.rh.pericalcarine 1.5878 0.1146  0.0096 2.2815 0.3441
73 D VOLctx.rh.postcentral  1.7565 0.0812 1.2943 3.0605 0.2734
74 D VOLctx.rh.posteriorcingulate  1.5171 0.1315 2.0716 1.4731 0.3441
75 D VOLctx.rh.precentral  2.4918 0.0139 0.9967 3.7013 0.0762
76 D VOLctx.rh.precuneus  2.0231 0.0450  0.1921 2.5419 0.1737
77 D VOLctx.rh.rostralanteriorcingulate 2.2083 0.0288 1.3734 2.3606 0.1362
78 D VOLctx.rh.rostralmiddlefrontal  2.6842 0.0081 0.5804 2.2235 0.0577
79 D VOLctx.rh.superiorfrontal  3.0013 0.0032 1.1011 3.2699 0.0344
80 D VOLctx.rh.superiorparietal  2.7495 0.0067 0.9014 2.0779 0.0574
81 D VOLctx.rh.superiortemporal 0.4377 0.6623 1.2455 4.4002 0.7712
82 D VOLctx.rh.supramarginal  2.4794 0.0143 2.7408 3.0429 0.0762
83 D VOLctx.rh.frontalpole 1.1256 0.2623  0.1784 1.9185 0.4644
84 D VOLctx.rh.temporalpole 0.7274 0.4682 0.5099 3.7696 0.6682
85 D VOLctx.rh.transversetemporal 1.1426 0.2551 0.6448 3.2405 0.4614
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but we did not find significant effects (age and baseline volume correlates strongly across almost all
regions – Supplementary file 5).
Discussion
This study investigated the relationship between electric field, volume change and clinical response
to ECT. We used a large sample of subjects with depression receiving ECT with right unilateral elec-
trode placement from the GEMRIC database. The key findings included a lateralization (right >left)
of the electric field and changes in regional brain volume in association with ECT. The use of right
unilateral electrode placement, which elicits greater right hemisphere electric fields, can thus be dis-
sociated from generalized seizure activity such that their contributions to antidepressant mechanisms
may be at least partially distinct. Further, regional volume increase and electric field distributions
were strongly related, especially in the left hippocampus and left amygdala. Here, the observed rela-
tionships between electric field and volume change suggest that a minimum electric field of 30–40
V/m is necessary for subsequent changes in brain structure, and that EF may have a ‘ceiling effect’
above approximately 100 V/m as illustrated for right hippocampal volume (see Figure 3). However,
volume change and electric field were not statistically related to clinical response after controlling
for age, number of ECT sessions and site. Below, we discuss potential mechanisms for electric field
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Figure 3. Individual specific relationship between EF and volume change in the hippocampus. Left: Scatterplot of EF versus volume change in the
hippocampus (t = 5.97, df = 300, r = 0.33, p < 0.0001, left and right side together). There is a significant relationship on the left side (orange dots; t =
4.53, df = 149, r = 0.35, p < 0.0001), but not on the right side (probably due to ceiling effect) (t = 1.59, df = 149, r = 0.13, p = 0.11). Right: The difference
in right and left hippocampal volume changes is significant (t = 7.76, df = 150, mean difference = 0.011, p < 0.0001).
The online version of this article includes the following source data and figure supplement(s) for figure 3:
Source data 1. Left and right hippocampal EF and volume change in 151 individual.
Figure supplement 1. Hippocampal EF and volume change.
Figure supplement 1—source data 1. Hippocampal EF and volume change: permutation values.
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and volume change that may be considered both independent and synergistic with seizure activity.
We also discuss potential future directions to elucidate the role of electric field distributions with
clinical response.
The biological underpinnings of ECT-mediated volume change (Oltedal et al., 2018;
Ousdal et al., 2019) could be related to seizure activity, cerebral blood flow, electric field strength,
or synergy between the generalized seizure and electric field (e.g. the electric field determines site
and focality of seizure initiation, which can subsequently affect seizure propagation and termination).
Several neuroplastic mechanisms including neurogenesis, angiogenesis, synaptogenesis, gliogenesis
may be specific to the rapidly changing electric field (Bouckaert et al., 2014; Tang et al., 2017).
Although heavily debated (Sorrells et al., 2018; Boldrini et al., 2018; Andreae, 2018), the support
for adult neurogenesis is based on pre-clinical studies demonstrating neuronal division and differen-
tiation related to suprathreshold electric stimulation (Scott et al., 2000; Madsen et al., 2000;
Perera et al., 2007; Segi-Nishida, 2011). However, neurogenesis as the sole mechanism of neuro-
plasticity may be incompatible with the time frame and expansive volume change. Specifically, the
ECT series is less than one month in duration, but pre-translational investigations have established
that adult neurogenesis may take up to six months (Kohler et al., 2011). Furthermore, adult neuro-
genesis is limited to the hippocampus and olfactory bulb and does not support the volume change
in 82 out of 85 regions demonstrated in our investigation (Kornack and Rakic, 1999). Alternatively,
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Figure 4. Individual specific relationship between EF and volume change in the amygdala. Left: Scatterplot of EF versus volume change in the
amygdala (t = 11.35, df = 300, r = 0.55, p<0.0001; left and right side together). Both the left (orange dots) and right (blue dots) hemisphere shows
highly significant relationships (t = 4.01, df = 149, r = 0.31, p=0.0001; and t = 4.02, df = 149, r = 0.31, p=0.0001). Right: The difference in right and left
amygdala volume changes is significant (t = 13.58, df = 150, mean difference = 0.029, p<0.0001).
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. Left and right amygdala EF and volume change in 151 individual.
Figure supplement 1. Amygdala EF and volume change.
Figure supplement 1—source data 1. Amygdala EF and volume change: permutation values.
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volume change may be related to fluid shifts due to vascularization (Hellsten et al., 2004), blood
flow changes (Milo et al., 2001; Leaver et al., 2019) and inflammation (Wennstro¨m et al., 2004;
Jansson et al., 2009; Fluitman et al., 2011; van Buel et al., 2015; Yrondi et al., 2018). Vasogenic
edema secondary to the hypertensive surge commonly associated with electroconvulsive stimulation
and possible breach of the blood brain barrier could be a potentially iatrogenic mechanism of volu-
metric increase, but the available pre-clinical and ECT-imaging studies (focused on T2 relaxtion time)
so far have produced mixed results (Andrade and Bolwig, 2014; Kunigiri et al., 2007;
Bolwig et al., 1977; Nordanskog et al., 2010; Takamiya et al., 2018). The generalized seizure and
global changes in blood flow would not explain the laterality of volumetric changes (right >left) ipsi-
lateral to the hemisphere of stimulation as seen in our current and previous investigations
(Abbott et al., 2014; Dukart et al., 2014; Pirnia et al., 2016; Bouckaert et al., 2016;
Sartorius et al., 2016; Cano et al., 2018). The laterality with electric field and volume change sug-
gest a mechanistic role of the electric field that may be independent or synergistic with seizure gen-
eration. Pre-translational investigations have demonstrated that increased stimulus charge increased
dendritic arborization in a dose-related fashion (Smitha et al., 2014). Furthermore, the behavioral
improvement after electroconvulsive stimulation are related to increased dendritic complexity, syn-
aptic remodeling, and neuronal survival (Jonckheere et al., 2018). However, additional pre-clinical
studies are clearly needed to resolve the mechanistic link between electric field and neuroplasticity.
Our original hypothesis was that a) local electric field had a causal role in clinical outcome and
that b) the corresponding volume change was mediating this relationship. In order to support this
model, data analysis should have indicated 1) a significant correlation between volume change and
electric field, 2) a significant correlation between clinical outcome and volume change, and 3) that
only the effect of volume change is significant in a multilinear regression model when both electric
field and volume change is added as covariates (outcome ~volume change + electric field). However,
since volume change showed no correlation with clinical change, neither in this dataset, nor in the
recently published broader dataset with more heterogeneous ECT electrode placement
(Ousdal et al., 2019), only the first half of this model, namely that electric field strength was associ-
ated with volume change, was supported by our data.
The null relationship between electric field, volume change and clinical outcome may be attrib-
uted to demographic (age) and other treatment related factors (number of sessions, rate of
Table 2. Clinical and demographics summary.
Table 2A Overall Summary
Site N
Age
(sd)
Medications
(med. free, SSRI/SNRI, TCA, AP*)
Average
number of
ECT Baseline MADRS D MADRS (%)
All 151 57.5
(17.1)
69,65,10,62 10.6 33.9 61.3
Female 92 56.4 (18.4) 42,36,8,42 10.4 34.4 63.4
Male 59 59.3
(14.7)
27,29,2,20 10.9 33.3 58.1
Table 2B Site Summary
Site N Age (mean)
Age
(sd) Baseline MADRS D MADRS (%)
1 30 39.87 12.68 40.73 45.12
2 33 64.48 8.93 31.36 69.48
3 16 73.62 12.45 29.56 77.24
4 23 46.87 9.19 29.96 43.18
5 2 62.50 0.71 36.75 32.03
6 18 48.50 16.77 33.83 57.12
7 29 72.66 7.57 35.07 79.13
*med. free: medication free, SSRI: selective serotonin reuptake inhibitor, SNRI: serotonin and norepinephrine reuptake inhibitors, TCA: tricyclic antidepres-
sants, AP: antipsychotic medications, there were not patients on MAO inhibitors.
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response). For example, age-related structural brain changes may mediate these relationships and
thus were an important consideration in our analysis. Our results are consistent with previous ECT
investigations demonstrating that older patients often have higher response rates (O’Connor et al.,
2001; Nordenskjo¨ld et al., 2012; Brus et al., 2017). Previous electric field modeling investigations
have demonstrated that age-related structural brain changes modulate the spatial distribution of the
calculated electric field (Deng et al., 2009). However, when including age in the assessment with
electric field, volume change and clinical outcome, our results suggest more complex or alternative
mechanisms underlie differential age-related response to ECT.
Additionally, it was necessary to control in our regression models for the number of ECT treat-
ments. In our earlier paper (Oltedal et al., 2018) we found a mild effect between hippocampus vol-
ume change and clinical response, but, counterintuitively, increased volume change was associated
with worse outcomes. However, this relationship was completely absent when we controlled for the
number of ECTs. We have previously demonstrated a dose-response relationship between hippo-
campal volume change and the number of ECT sessions (Oltedal et al., 2018). Also, due to the nat-
uralistic design, clinical outcome correlated with the number of ECT sessions: patients with the
worse or slower response received more ECT treatments. Mediation analysis supported a very simi-
lar situation in our sample with p=0.035 and p=0.034 in L and R Hippocampus reflectively (Sobel
test).
It was, therefore, necessary to control for the number of ECT sessions to avoid detecting spurious
correlations between clinical response and volume change. Without an earlier, fixed mid-point
assessment, we are unable to assess differences in rate of change, which could be relevant to spe-
cific depression subtypes (Drysdale et al., 2017) and eventual clinical response. Notably, the overall
volume changes measured in this study do not permit us to make conclusions about more structure-
function relationships that might be better assessed with shape or hippocampal subfield analysis
(Roddy et al., 2019; Takamiya et al., 2019).
Finally, the volume change required for response may be non-linear. A minimum electric field of
30–40 V/m may be necessary to induce neuroplasticity. Increasing the electric field between 30–40
V/m and 100 V/m is related to a monotonic increase in hippocampal volume. Electric field above 100
V/m is still associated with hippocampal neuroplasticity but the dose-response relationship may be
less robust and represent a ceiling effect of electric-field induced neuroplasticity as illustrated in Fig-
ure 3. Surpassing the neurpolasticity threshold (100 V/m) appears to be unrelated to further volu-
metric increases and antidepressant response. Thus, the relationship between e-field and volumetric
changes may be conceptualized as a ‘neuroplasticity threshold’ between 30–40 V/m and 100 V/m.
This thresholding effect also preserves the laterality of electric field and neuroplasticity. Our sample
was limited to right unilateral electrode placement. In the left hippocampus, the maximum electric
field is ~80 V/m (Figure 3) and below the 100 V/m ‘ceiling effect’ noted in the right hemisphere.
Consequently, in our right unilateral sample, hippocampal electric field and related changes in neu-
roplasticity will demonstrate laterality effects.
Our findings indicate widespread and robust volume changes in both cortical and subcortical
regions. The GEMRIC group recently published a comprehensive paper on a larger dataset with sim-
ilar volumetric findings. The processing pipeline that was used has been validated against many
commonly used tools for estimating longitudinal volume change (Holland et al., 2012;
Holland et al., 2011). Specifically, it was previously compared head-to-head with FreeSurfer 5.3,
and we have already repeated this comparison for data from one of the GEMRIC sites
(Oltedal et al., 2017). Our comparisons of power estimations based on results from the FreeSurfer
longitudinal pipeline and Quarc (Table 3 in Oltedal et al., 2017) were in line with those of the earlier
publications. In agreement with previous research, the effect sizes show regional differences indicat-
ing that previous studies with smaller sample sizes were underpowered to detect cortical changes,
and that can explain why they only found subcortical volume increase. Furthermore, using the same
methodology, we did not find any significant volume change in the 95 healthy controls (received no
ECT) who were imaged at two time points (Ousdal et al., 2019).
We acknowledge several limitations that influence result interpretation. First, our approach was
agnostic to seizure duration, which may contribute to the effects of EF on regional volumes and clini-
cal response. This investigation also does not preclude the possible role of seizure in both volume
changes and clinical outcomes. However, the selection of right unilateral electrode placement sub-
jects does attempt to disentangle the impact of the generalized seizure from the lateralized electric
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field. Second, the electric field models a single current pulse and ignores the temporal dynamics of
stimulus (pulse-width, and frequency and duration of the pulse train) (Swartz, 2006; Swartz et al.,
2012). Differences in pulse width, for example, may affect volume change and clinical outcomes.
Furthermore, differences in maximal charge, unrelated to current amplitude, are different between
the US and Europe (Europe permits twice the US maximal charge). The analysis included patients
treated with one of two different ECT devices. We controlled for the differences in current related to
the two devices with the electric field modeling (800mA for the spECTrum, 900mA for the Thyma-
tron), but we are unable to control for other differences in stimulus delivery related to the device.
Third, the study sites in this mega-analysis likely include heterogeneity in patient selection and other
treatment related factors that were not controlled. Despite these site differences, the large sample
size and additional inclusion criteria permitted whole brain analyses with electric field, and within-
subject volume change and clinical outcomes. Finally, we did not assess cognitive correlates with
electric field or volume change. General clinical experience and previous results from studies investi-
gating electrode placement strategies indicate that ECT-mediated neurocognitive side effects are
influenced by electrode placement (d’Elia, 1970; Sackeim et al., 2000; Kolshus et al., 2017). Previ-
ous electric field studies on simulated head models have already shown that cognitive side effects
might be attributed to the electric field spatial distributions associated with different electrode
placements (Bai et al., 2017; Deng et al., 2011). These considerations would indicate that these vol-
umetric changes might be associated with cognitive side-effects, but further studies are needed to
confirm this relationship.
Conclusion
This investigation is the first demonstration that the ECT-induced electric field is related to increases
in cortical and subcortical structures. These results support that the electric field, independent or
synergistic with seizure activity and other stimulation parameters, can have a profound effect on the
biology of the human brain. The electric path originates from the ECT electrode handle, which deliv-
ers a constant stimulus current from the scalp. From the scalp, the electric path travels through skin,
skull, cerebral spinal fluid, and brain. Each tissue type has different conductive properties and abun-
dant individual variability (Deng et al., 2015). This variability creates different electric field doses
despite the similar current at the scalp. These differences in current may lead to both differences in
volume changes as well as clinical outcomes. In our investigation, the electric field-induced volume
change in the bilateral amygdala and the left hippocampus suggests regional specificity, but the
association of these volumetric changes with clinical outcomes remains elusive. Better controlled
prospective trials are needed to answer if these robust volume changes and corresponding electric
field distributions are associated with any clinical or cognitive consequences.
Materials and methods
Participants
GEMRIC is a multi-site consortium focused on improving and individualizing ECT by researching the
still elusive mechanisms of action and response-related biomarkers (Oltedal et al., 2017). Patients in
the GEMRIC database participated in clinical and imaging assessments pre- and post-ECT series. To
control for the differential effects of electrode placement on electric fields, we only included subjects
who received high-dose (six times the seizure threshold) right unilateral electrode placement
throughout the ECT series. We screened 281 patients from 10 sites (Oltedal et al., 2018), and data
were included from 7 GEMRIC sites with the RUL only criteria (n = 151, 92 F, age: 57.5 ± 17.1, 12
with bipolar depression, 139 with major depression, demographic summary is in Table 2A and B).
Depression severity was assessed with the Montgomery–A˚sberg Depression Rating Scale (MADRS)
(Montgomery and Asberg, 1979) or 17- or 24-item Hamilton Depression Rating Scale (HAM-D)
(Hamilton, 1960). For sites collecting only the 17- or 24-item HAM-D, a validated equation was used
to convert the 17-item HAM-D to a MADRS score (Heo et al., 2007). Clinical response was esti-
mated as the percentage change of the MADRS scores (DMADRS = (MADRSTP1-MADRSTP2)/
MADRSTP1). Although more conservative than absolute change or post-ECT depression outcomes
(Vickers, 2001), the rationale for the use of the proportional change score was to control for the var-
iability of the pre-ECT MADRS. The range of the number of sessions for the ECT series was between
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7 and 20. Half of the subjects were medication free during the ECT series (n = 69). Concurrent phar-
macotherapy for the remaining subjects was as follows: selective serotonin reuptake inhibitors (SSRI,
n = 28), serotonin norepinephrine reuptake inhibitors (SNRI, n = 37), tricyclic antidepressants (TCA,
n = 10), and no record of concurrent medications (n = 6). Only five subjects received medication
changes during the ECT series (two medication free subjects started SSRI and TCA, one subject
switched from SNRI to TCA, one from SNRI to TCA and one from SSRI to SNRI). The results did not
change if we used medication status or diagnosis (bipolar or unipolar depression) as a nuisance vari-
able in the linear models of this study. All sites’ contributing data (Table 2B) received approval by
their local ethical committees or institutional review board, and the centralized mega-analysis was
approved by the Regional Ethics Committee South-East in Norway (2013/1032 ECT and Neuroradi-
ology, June 1, 2015).
Imaging
The image processing methods have been detailed previously (Oltedal et al., 2018; Oltedal et al.,
2017). In brief, the sites provided longitudinal 3T T1-weighted MRI images (at baseline and after the
end of the course of ECT) with a minimal resolution of 1.3 mm in any direction (detailed parameters
in Supplementary file 6). The raw DICOM images were uploaded and analyzed on a common server
at the University of Bergen, Norway. To guarantee reproducibility, in addition to the common plat-
form, the processing pipelines were implemented in a docker environment (Merkel, 2014). First,
images were corrected for scanner-specific gradient-nonlinearity (Jovicich et al., 2006). Further
processing was performed with FreeSurfer version 5.3, which includes segmentation of subcortical
structures (Fischl et al., 2002) and automated parcellation of the cortex (Desikan et al., 2006). In
addition to brainstem and bilateral cerebellum, this automated process identified 33 cortical and
eight subcortical regions in each hemisphere. Altogether this resulted in 85 regions of interest (ROIs)
(Supplementary file 1). Next Quarc (Holland et al., 2011) was used for unbiased, within-subject
assessment of estimation of longitudinal volume change (DVol - %) (Figure 5). In summary, we calcu-
lated bias-free estimation of volumetric change from 85 brain regions across the timespan of an ECT
course in 151 individuals who received between 4 to 20 ECT sessions (1 ½ week to 2 month).
Electric Field modeling
We estimated ECT-induced electric fields with Realistic Volumetric-Approach to Stimulate Transcra-
nial Electric Stimulation (ROAST v1.1) (Huang et al., 2017). After segmentation of the structural MRI
T1-weighted images, ROAST builds a three-dimensional tetrahedral mesh model of the head. The
Figure 5. Illustration of the methods. We analyzed longitudinal structural MRI data from 151 individuals. We
calculated the volume change and the magnitude of electrical field in 85 regions across the human cortex and
subcortical structures.
Argyelan et al. eLife 2019;8:e49115. DOI: https://doi.org/10.7554/eLife.49115 13 of 20
Research article Human Biology and Medicine
segmentation identifies five tissue types: white and gray matter of the brain, cerebrospinal fluid,
skull, and scalp, and assigns them different conductivity values: 0.126 S/m, 0.276 S/m, 1.65 S/m,
0.01 S/m, and 0.465 S/m respectively. ECT electrodes of 5 cm diameter were placed over the C2
and FT8 EEG (10–20 system) sites. Study sites from the GEMRIC database used either the Thymatron
(Somatics, Venice, Florida, six sites, N = 121) or spECTrum (MECTA Corp., Tualatin, Oregon, one
site, N = 30) devices. The electric field was solved using the finite-element method with unit current
on the electrodes and, subsequently, it was scaled to the current amplitude of the specific devices
(Thymatron 900 mA, spECTrum 800 mA). These procedures resulted in a voxel-wise electric field dis-
tribution map in each individual. We calculated the average electric field across the 85 three-dimen-
sional ROIs in every individual (Figure 5) based on the Freesurfer parcellations and segmentations.
The voxel values with the top and lowest one percentile in each ROI were omitted during calcula-
tions to reduce boundary effects.
Statistical analysis
Laterality of electric field and volume change
Our statistical analysis was performed in R (R Development Core Team, 2013), and the underlying
analyses can be found at https://github.com/argyelan/Publications/ (copy archived at https://github.
com/elifesciences-publications/Publications-1) in org mode (Schulte et al., 2012). We first calculated
the effect sizes (Cohen’s d) for longitudinal volume changes in each region. We assessed the correla-
tions between the average electric fields and the effect sizes of volume changes across all the 85
regions. We further explored the hemispheric differences by calculating the pair-wise difference in
volume changes across the corresponding ROIs (42 pairs). We defined the laterality index as the
effect size of the pair-wise difference for both EF and DVol among homotopic ROIs. We then
assessed the correlations between laterality indices of EF and DVol across the 42 pairs of regions.
Electric field and volume change
We assessed the relationship between EF and D Vol with the following linear mixed effect model in
all 85 regions: 1) DVol ~EF + Age + number of ECT sessions + site (where EF, age, and number of
ECT sessions were fixed effects, and site was random effect, while the dependent variable was vol-
ume change). Age, number of ECT sessions, and site, considered as nuisance variables, were
included based on our prior observations of an inverse relationship between ECT session number
and response (Oltedal et al., 2018). Further, age is also shown to impact clinical response (older
patients have increased probability of response, in our sample: t = 5.75, df = 149, r = 0.43, p<10 7)
and age-related changes on brain structure are related to EF (Deng et al., 2015). We used Benja-
mini and Hochberg false discovery rate (FDR) correction method (Benjamini and Hochberg, 1995)
to control for multiple comparisons across 85 ROIs, where a conservative FDR -corrected p<0.01
was chosen as the statistical threshold of significance.
Electric field, volume change, and clinical response
We assessed the relationship between DMADRS and EF and D Vol with the following linear mixed
effect model in all 85 regions: 1) DMADRS ~ DVol + Age + number of ECT sessions + site; and 2)
DMADRS ~EF + Age + number of ECT sessions + site (site as random effect). We used the same
Benjamini and Hochberg FDR correction for multiple comparison corrections. In addition to analyz-
ing the percentage change of the clinical response, we also evaluated the same models with abso-
lute changes, using baseline MADRS as a covariate. We provided the results of these analyses in the
second half of the corresponding Supplementary Files.
Acknowledgements
This work was supported by the Western Norway Regional Health Authority (#911986 to KJO and #
912238 to LO) and the University of Bergen, Norway, the Fulbright Program (to LO); the National
Institute of Mental Health (#MH092301, #MH110008, #MH102743) (to KN and RE), #MH119616 (to
MA), #MH111826 (to CA) and the German Research Foundation (DFG FOR2107, DA1151/5-1 and
DA1151/5-2; SFB-TRR58, Projects C09 and Z02) (UD) and Innovative medical research (RE111604,
Argyelan et al. eLife 2019;8:e49115. DOI: https://doi.org/10.7554/eLife.49115 14 of 20
Research article Human Biology and Medicine
RE111722) (to RR). ZD is supported by the National Institute of Mental Health Intramural Research
Program (ZIAMH00295).
We would like to acknowledge the logistic and academic support of the whole GEMRIC consor-
tium outside of the authorship of this manuscript. These collaborators were not only actively involved
in this manuscript but their valuable feedback on our regular meetings contributed to this manu-
script in many levels. The full overview of the GEMRIC board members can be find here: https://
helse-bergen.no/en/avdelinger/psykisk-helsevern/forskingsavdelinga-divisjon-psykisk-helsevern/gem-
ric-the-global-ect-mri-research-collaboration/gemric-the-global-ectmri-research-collaboration.
Additional information
Competing interests
Marom Bikson: reports that The City University of New York (CUNY) has intellectual property (IP) on
neuro-stimulation system and methods with MB as inventor; serves on the scientific advisory boards
of Boston Scientific and GSK; has equity in Soterix Medical. Anders M Dale: reports that he is a
Founder of and holds equity in CorTechs Labs, Inc, and serves on its Scientific Advisory Board. He is
a member of the Scientific Advisory Board of Human Longevity, Inc and receives funding through
research agreements with General Electric Healthcare and Medtronic, Inc. The other authors declare
that no competing interests exist.
Funding
Funder Grant reference number Author
National Institute of Mental
Health
MH092301 Randall Espinoza
Katherine L Narr
National Institute of Mental
Health
MH110008 Randall Espinoza
Katherine L Narr
National Institute of Mental
Health
MH102743 Randall Espinoza
Katherine L Narr
Western Norway Regional
Health Authority
911986 Ketil J Oedegaard
Western Norway Regional
Health Authority
912238 Leif Oltedal
Deutsche Forschungsge-
meinschaft
DFG FOR2107 Udo Dannlowski
Deutsche Forschungsge-
meinschaft
SFB-TRR58 Udo Dannlowski
Deutsche Forschungsge-
meinschaft
Project C09 Udo Dannlowski
Innovative Medical Research RE111604 Ronny Redlich
National Institute of Mental
Health
ZIAMH00295 Zhi-De Deng
National Institute of Mental
Health
MH119616 Miklos Argyelan
National Institute of Mental
Health
MH111826 Christopher Abbott
Deutsche Forschungsge-
meinschaft
DA1151/5-1 Udo Dannlowski
Deutsche Forschungsge-
meinschaft
DA1151/5-2 Udo Dannlowski
Innovative Medical Research RE111722 Ronny Redlich
Deutsche Forschungsge-
meinschaft
Project Z02 Udo Dannlowski
University of Bergen Fulbright Program Leif Oltedal
Argyelan et al. eLife 2019;8:e49115. DOI: https://doi.org/10.7554/eLife.49115 15 of 20
Research article Human Biology and Medicine
The funders had no role in study design, data collection and interpretation, or the
decision to submit the work for publication.
Author contributions
Miklos Argyelan, Conceptualization, Resources, Data curation, Software, Formal analysis, Supervi-
sion, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project adminis-
tration, Writing—review and editing; Leif Oltedal, Conceptualization, Resources, Data curation,
Software, Formal analysis, Supervision, Funding acquisition, Validation, Visualization, Methodology,
Writing—original draft, Project administration, Writing—review and editing; Zhi-De Deng, Supervi-
sion, Methodology, Writing—review and editing; Benjamin Wade, Conceptualization, Software, For-
mal analysis, Methodology, Writing—original draft, Writing—review and editing; Marom Bikson,
Conceptualization, Software, Methodology, Writing—review and editing; Andrea Joanlanne, Data
curation, Writing—review and editing; Sohag Sanghani, Marta Cano, Akihiro Takamiya, Jesus Pujol,
Conceptualization, Writing—review and editing; Hauke Bartsch, Resources, Software, Formal analy-
sis, Methodology, Project administration; Anders M Dale, Conceptualization, Resources, Data cura-
tion, Software, Methodology; Udo Dannlowski, Annemiek Dols, Conceptualization, Data curation,
Project administration, Writing—review and editing; Verena Enneking, Randall Espinoza, Ute Kessler,
Ketil J Oedegaard, Mardien L Oudega, Ronny Redlich, Max L Stek, Louise Emsell, Filip Bouckaert,
Pascal Sienaert, Conceptualization, Data curation, Writing—review and editing; Katherine L Narr,
Conceptualization, Data curation, Supervision, Methodology, Writing—review and editing; Indira
Tendolkar, Conceptualization, Supervision, Project administration, Writing—review and editing; Phi-
lip van Eijndhoven, Conceptualization, Data curation, Methodology, Writing—review and editing;
Georgios Petrides, Conceptualization, Resources, Data curation, Methodology, Writing—original
draft, Project administration, Writing—review and editing; Anil K Malhotra, Conceptualization,
Resources, Data curation, Methodology, Writing—review and editing; Christopher Abbott, Concep-
tualization, Resources, Data curation, Software, Formal analysis, Supervision, Investigation, Visualiza-
tion, Methodology, Writing—original draft, Project administration, Writing—review and editing
Author ORCIDs
Miklos Argyelan https://orcid.org/0000-0002-7254-1776
Marta Cano http://orcid.org/0000-0003-0675-9483
Ethics
Human subjects: All sites’ contributing data received approval by their local ethical committees or
institutional review board, and the centralized mega-analysis was approved by the Regional Ethics
Committee South-East in Norway (2013/1032 ECT and Neuroradiology, June 1, 2015).
Decision letter and Author response
Decision letter https://doi.org/10.7554/eLife.49115.SA1
Author response https://doi.org/10.7554/eLife.49115.SA2
Additional files
Supplementary files
. Source code 1. Once EF and DVol were collected across 85 ROI in 151 subjects, all the rest of the
calculations were carried out in R environment.This file is the source code of these calculations orga-
nized in org-mode (https://orgmode.org/) for reproducibility.
. Supplementary file 1. Volume changes following electroconvulsive treatment (ECT).One sample
t-test in each ROIs. The table indicates t, uncorrected p, Cohen’s d effect size, and FDR corrected p
values. This sample is a sub-cohort of a recent publication of 331 subjects (Ousdal et al., 2019). In
contrast with that publication we included patients with RUL only electrode placement.
. Supplementary file 2. The laterality of volume changes after RUL ECT.The table contains the results
of 42 pairwise t-tests between the volume changes of the right and the left side of the
Argyelan et al. eLife 2019;8:e49115. DOI: https://doi.org/10.7554/eLife.49115 16 of 20
Research article Human Biology and Medicine
corresponding regions. The table indicates t, uncorrected p, mean, Cohen’s d effect size and FDR
corrected p values.
. Supplementary file 3. The relationship between clinical response and volume change across individ-
uals.The table indicates the t values of the corresponding clinical covariates modeled as fixed effects:
volume change, age, and number of ECT.
. Supplementary file 4. The relationship between clinical response and electric field across individu-
als.The table indicates the t values of the corresponding clinical covariates modeled as fixed effects:
electric field, age, and number of ECT.
. Supplementary file 5. The relationship between the baseline volume and age across 85 ROIs.
. Supplementary file 6. MRI summary.The table indicates the parameters of the structural image
acquisition across sites.
. Transparent reporting form
Data availability
Source data files (.csv) including processed data have been provided for Figures 1–4, Figure 3—fig-
ure supplement 1 and Figure 4—figure supplement 1. Raw data cannot be made available publicly
because we do not have consent or ethical approval for this and the data cannot be anonymised.
The data are stored on a secure centralized server at the University of Bergen, Norway. Participating
GEMRIC sites have access to the raw data according to specific data policy and safety rules of the
consortium, and in accord with the approval from the ethical committee. The GEMRIC consortium
welcomes new members who are interested in the neuroimaging research of ECT. We hold board
meetings twice a year when new members can apply to join and gain access to the database avail-
able on the GEMRIC servers. For more about the application process please visit https://mmiv.no/
how-to-join-gemric/ or write to Leif Oltedal (leif.oltedal@uib.no). General information about the con-
sortium can be found on the following website: https://mmiv.no/gemric/. For transparency and
reproducibility, the entire analytical approach is uploaded to the https://github.com/argyelan/Publi-
cations/tree/master/ECTEFvsVOLUME (R scripts in org mode), and also was uploaded to eLife.
References
Abbott CC, Jones T, Lemke NT, Gallegos P, McClintock SM, Mayer AR, Bustillo J, Calhoun VD. 2014.
Hippocampal structural and functional changes associated with electroconvulsive therapy response.
Translational Psychiatry 4:e483. DOI: https://doi.org/10.1038/tp.2014.124, PMID: 25405780
Andrade C, Bolwig TG. 2014. Electroconvulsive therapy, hypertensive surge, blood-brain barrier breach, and
amnesia: exploring the evidence for a connection. The Journal of ECT 30:160–164. DOI: https://doi.org/10.
1097/YCT.0000000000000133, PMID: 24800688
Andreae LC. 2018. Adult neurogenesis in humans: dogma overturned, again and again? Science Translational
Medicine 10:eaat3893. DOI: https://doi.org/10.1126/scitranslmed.aat3893
Bai S, Ga´lvez V, Dokos S, Martin D, Bikson M, Loo C. 2017. Computational models of bitemporal, bifrontal and
right unilateral ECT predict differential stimulation of brain regions associated with efficacy and cognitive side
effects. European Psychiatry 41:21–29. DOI: https://doi.org/10.1016/j.eurpsy.2016.09.005, PMID: 28049077
Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to
multiple testing. Journal of the Royal Statistical Society: Series B 57:289–300. DOI: https://doi.org/10.1111/j.
2517-6161.1995.tb02031.x
Bikson M, Rahman A, Datta A, Fregni F, Merabet L. 2012. High-Resolution modeling assisted design of
customized and individualized transcranial direct current stimulation protocols. Neuromodulation: Technology
at the Neural Interface 15:306–315. DOI: https://doi.org/10.1111/j.1525-1403.2012.00481.x
Boldrini M, Fulmore CA, Tartt AN, Simeon LR, Pavlova I, Poposka V, Rosoklija GB, Stankov A, Arango V, Dwork
AJ, Hen R, Mann JJ. 2018. Human hippocampal neurogenesis persists throughout aging. Cell Stem Cell 22:
589–599. DOI: https://doi.org/10.1016/j.stem.2018.03.015, PMID: 29625071
Bolwig TG, Hertz MM, Westergaard E. 1977. Blood-brain barrier permeability to protein during epileptic seizures
in the rat. Acta Neurologica Scandinavica 64:226–227.
Bouckaert F, Sienaert P, Obbels J, Dols A, Vandenbulcke M, Stek M, Bolwig T. 2014. ECT: its brain enabling
effects: a review of electroconvulsive therapy-induced structural brain plasticity. The Journal of ECT 30:143–
151. DOI: https://doi.org/10.1097/YCT.0000000000000129, PMID: 24810772
Bouckaert F, De Winter FL, Emsell L, Dols A, Rhebergen D, Wampers M, Sunaert S, Stek M, Sienaert P,
Vandenbulcke M. 2016. Grey matter volume increase following electroconvulsive therapy in patients with late
life depression: a longitudinal MRI study. Journal of Psychiatry & Neuroscience 41:105–114. DOI: https://doi.
org/10.1503/jpn.140322, PMID: 26395813
Argyelan et al. eLife 2019;8:e49115. DOI: https://doi.org/10.7554/eLife.49115 17 of 20
Research article Human Biology and Medicine
Brus O, Cao Y, Gustafsson E, Hulte´n M, Landen M, Lundberg J, Nordanskog P, Nordenskjo¨ld A. 2017. Self-
assessed remission rates after electroconvulsive therapy of depressive disorders. European Psychiatry 45:154–
160. DOI: https://doi.org/10.1016/j.eurpsy.2017.06.015, PMID: 28865389
Cano M, Martı´nez-Zalacaı´n I, Bernabe´u-Sanz A´, Contreras-Rodrı´guez O, Herna´ndez-Ribas R, Via E, de Arriba-
Arnau A, Ga´lvez V, Urretavizcaya M, Pujol J, Mencho´n JM, Cardoner N, Soriano-Mas C. 2017. Brain volumetric
and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal
neuroimaging study. Translational Psychiatry 7:e1023. DOI: https://doi.org/10.1038/tp.2016.267, PMID: 2
8170003
Cano M, Lee E, Cardoner N, Martı´nez-Zalacaı´n I, Pujol J, Makris N. 2018. Brain volumetric correlates of right
unilateral versus bitemporal electroconvulsive therapy for Treatment-Resistant depression. Journal of
Neuropsychiatry and Clinical Neurosciences. DOI: https://doi.org/10.1176/appi.neuropsych.18080177
Deng ZD, Lisanby SH, Peterchev AV. 2009. Effect of anatomical variability on neural stimulation strength and
focality in electroconvulsive therapy (ECT) and magnetic seizure therapy (MST). 2009 annual international
conference of the IEEE engineering in medicine and biology society. Presented at the 2009 Annual
International Conference of the IEEE Engineering in Medicine and Biology Society.
Deng Z-D, Lisanby SH, Peterchev AV. 2011. Electric field strength and focality in electroconvulsive therapy and
magnetic seizure therapy: a finite element simulation study. Journal of Neural Engineering 8:016007.
DOI: https://doi.org/10.1088/1741-2560/8/1/016007
Deng ZD, Lisanby SH, Peterchev AV. 2015. Effect of anatomical variability on electric field characteristics of
electroconvulsive therapy and magnetic seizure therapy: a parametric modeling study. IEEE Transactions on
Neural Systems and Rehabilitation Engineering 23:22–31. DOI: https://doi.org/10.1109/TNSRE.2014.2339014,
PMID: 25055384
Desikan RS, Se´gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman
BT, Albert MS, Killiany RJ. 2006. An automated labeling system for subdividing the human cerebral cortex on
MRI scans into gyral based regions of interest. NeuroImage 31:968–980. DOI: https://doi.org/10.1016/j.
neuroimage.2006.01.021, PMID: 16530430
Drysdale AT, Grosenick L, Downar J, Dunlop K, Mansouri F, Meng Y, Fetcho RN, Zebley B, Oathes DJ, Etkin A,
Schatzberg AF, Sudheimer K, Keller J, Mayberg HS, Gunning FM, Alexopoulos GS, Fox MD, Pascual-Leone A,
Voss HU, Casey BJ, et al. 2017. Resting-state connectivity biomarkers define neurophysiological subtypes of
depression. Nature Medicine 23:28–38. DOI: https://doi.org/10.1038/nm.4246, PMID: 27918562
Dukart J, Regen F, Kherif F, Colla M, Bajbouj M, Heuser I, Frackowiak RS, Draganski B. 2014. Electroconvulsive
therapy-induced brain plasticity determines therapeutic outcome in mood disorders. PNAS 111:1156–1161.
DOI: https://doi.org/10.1073/pnas.1321399111, PMID: 24379394
d’Elia G. 1970. Unilateral electroconvulsive therapy. Acta Psychiatrica Scandinavica Supplement 215:1–98.
Fink M, Taylor MA. 2007. Electroconvulsive therapy: evidence and challenges. Jama 298:330–332. DOI: https://
doi.org/10.1001/jama.298.3.330, PMID: 17635894
Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D,
Klaveness S, Montillo A, Makris N, Rosen B, Dale AM. 2002. Whole brain segmentation: automated labeling of
neuroanatomical structures in the human brain. Neuron 33:341–355. DOI: https://doi.org/10.1016/s0896-6273
(02)00569-x, PMID: 11832223
Fluitman SB, Heijnen CJ, Denys DA, Nolen WA, Balk FJ, Westenberg HG. 2011. Electroconvulsive therapy has
acute immunological and neuroendocrine effects in patients with major depressive disorder. Journal of
Affective Disorders 131:388–392. DOI: https://doi.org/10.1016/j.jad.2010.11.035, PMID: 21183225
Hamilton M. 1960. A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry 23:56–62.
DOI: https://doi.org/10.1136/jnnp.23.1.56
Haq AU, Sitzmann AF, Goldman ML, Maixner DF, Mickey BJ. 2015. Response of depression to electroconvulsive
therapy: a meta-analysis of clinical predictors. The Journal of Clinical Psychiatry 76:1374–1384. DOI: https://doi.
org/10.4088/JCP.14r09528, PMID: 26528644
Hellsten J, Wennstro¨m M, Bengzon J, Mohapel P, Tingstro¨m A. 2004. Electroconvulsive seizures induce
endothelial cell proliferation in adult rat hippocampus. Biological Psychiatry 55:420–427. DOI: https://doi.org/
10.1016/j.biopsych.2003.08.013
Heo M, Murphy CF, Meyers BS. 2007. Relationship between the hamilton depression rating scale and the
Montgomery-Asberg depression rating scale in depressed elderly: a meta-analysis. The American Journal of
Geriatric Psychiatry 15:899–905. DOI: https://doi.org/10.1097/JGP.0b013e318098614e, PMID: 17911366
Holland D, Dale AM, Alzheimer’s Disease Neuroimaging Initiative. 2011. Nonlinear registration of longitudinal
images and measurement of change in regions of interest. Medical Image Analysis 15:489–497. DOI: https://
doi.org/10.1016/j.media.2011.02.005, PMID: 21388857
Holland D, McEvoy LK, Dale AM, Alzheimer’s Disease Neuroimaging Initiative. 2012. Unbiased comparison of
sample size estimates from longitudinal structural measures in ADNI. Human Brain Mapping 33:2586–2602.
DOI: https://doi.org/10.1002/hbm.21386, PMID: 21830259
Huang Y, Liu AA, Lafon B, Friedman D, Dayan M, Wang X, Bikson M, Doyle WK, Devinsky O, Parra LC. 2017.
Measurements and models of electric fields in the in vivo human brain during transcranial electric stimulation.
eLife 6:e18834. DOI: https://doi.org/10.7554/eLife.18834
Jansson L, Wennstro¨m M, Johanson A, Tingstro¨m A. 2009. Glial cell activation in response to electroconvulsive
seizures. Progress in Neuro-Psychopharmacology and Biological Psychiatry 33:1119–1128. DOI: https://doi.org/
10.1016/j.pnpbp.2009.06.007, PMID: 19540297
Argyelan et al. eLife 2019;8:e49115. DOI: https://doi.org/10.7554/eLife.49115 18 of 20
Research article Human Biology and Medicine
Jonckheere J, Deloulme JC, Dall’Igna G, Chauliac N, Pelluet A, Nguon AS, Lentini C, Brocard J, Denarier E,
Brugie`re S, Coute´ Y, Heinrich C, Porcher C, Holtzmann J, Andrieux A, Suaud-Chagny MF, Gory-Faure´ S. 2018.
Short- and long-term efficacy of electroconvulsive stimulation in animal models of depression: the essential role
of neuronal survival. Brain Stimulation 11:1336–1347. DOI: https://doi.org/10.1016/j.brs.2018.08.001,
PMID: 30146428
Joshi SH, Espinoza RT, Pirnia T, Shi J, Wang Y, Ayers B, Leaver A, Woods RP, Narr KL. 2016. Structural plasticity
of the Hippocampus and amygdala induced by electroconvulsive therapy in major depression. Biological
Psychiatry 79:282–292. DOI: https://doi.org/10.1016/j.biopsych.2015.02.029, PMID: 25842202
Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R, Kennedy D, Schmitt F, Brown G, Macfall J,
Fischl B, Dale A. 2006. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction
on phantom and human data. NeuroImage 30:436–443. DOI: https://doi.org/10.1016/j.neuroimage.2005.09.
046, PMID: 16300968
Kohler SJ, Williams NI, Stanton GB, Cameron JL, Greenough WT. 2011. Maturation time of new granule cells in
the dentate gyrus of adult macaque monkeys exceeds six months. PNAS 108:10326–10331. DOI: https://doi.
org/10.1073/pnas.1017099108, PMID: 21646517
Kolshus E, Jelovac A, McLoughlin DM. 2017. Bitemporal v. high-dose right unilateral electroconvulsive therapy
for depression: a systematic review and meta-analysis of randomized controlled trials. Psychological Medicine
47:518–530. DOI: https://doi.org/10.1017/S0033291716002737, PMID: 27780482
Kornack DR, Rakic P. 1999. Continuation of neurogenesis in the Hippocampus of the adult macaque monkey.
PNAS 96:5768–5773. DOI: https://doi.org/10.1073/pnas.96.10.5768, PMID: 10318959
Kunigiri G, Jayakumar PN, Janakiramaiah N, Gangadhar BN. 2007. MRI T(2) relaxometry of brain regions and
cognitive dysfunction following electroconvulsive therapy. Indian Journal of Psychiatry 49:195–199.
DOI: https://doi.org/10.4103/0019-5545.37321, PMID: 20661386
Leaver AM, Vasavada M, Joshi SH, Wade B, Woods RP, Espinoza R, Narr KL. 2019. Mechanisms of
antidepressant response to electroconvulsive therapy studied with perfusion magnetic resonance imaging.
Biological Psychiatry 85:466–476. DOI: https://doi.org/10.1016/j.biopsych.2018.09.021, PMID: 30424864
Lee WH, Deng Z-D, Kim T-S, Laine AF, Lisanby SH, Peterchev AV. 2012. Regional electric field induced by
electroconvulsive therapy in a realistic finite element head model: influence of white matter anisotropic
conductivity. NeuroImage 59:2110–2123. DOI: https://doi.org/10.1016/j.neuroimage.2011.10.029
Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstro¨m A. 2000. Increased neurogenesis in a
model of electroconvulsive therapy. Biological Psychiatry 47:1043–1049. DOI: https://doi.org/10.1016/S0006-
3223(00)00228-6, PMID: 10862803
Merkel D. 2014. Docker: lightweight linux containers for consistent development and deployment. Linux J.
http://dl.acm.org/citation.cfm?id=2600239.2600241 [Accessed June 20, 2019].
Milo TJ, Kaufman GE, Barnes WE, Konopka LM, Crayton JW, Ringelstein JG, Shirazi PH. 2001. Changes in
regional cerebral blood flow after electroconvulsive therapy for depression. The Journal of ECT 17:15–21.
DOI: https://doi.org/10.1097/00124509-200103000-00004, PMID: 11281509
Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. British Journal of
Psychiatry 134:382–389. DOI: https://doi.org/10.1192/bjp.134.4.382, PMID: 444788
Nordanskog P, Dahlstrand U, Larsson MR, Larsson EM, Knutsson L, Johanson A. 2010. Increase in hippocampal
volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging
study. The Journal of ECT 26:62–67. DOI: https://doi.org/10.1097/YCT.0b013e3181a95da8, PMID: 20190603
Nordenskjo¨ld A, von Knorring L, Engstro¨m I. 2012. Predictors of the short-term responder rate of
electroconvulsive therapy in depressive disorders–a population based study. BMC Psychiatry 12:115.
DOI: https://doi.org/10.1186/1471-244X-12-115, PMID: 22900754
O’Connor MK, Knapp R, Husain M, Rummans TA, Petrides G, Smith G, Mueller M, Snyder K, Bernstein H, Rush
AJ, Fink M, Kellner C. 2001. The influence of age on the response of major depression to electroconvulsive
therapy: a C.O.R.E. report. The American Journal of Geriatric Psychiatry 9:382–390. DOI: https://doi.org/10.
1097/00019442-200111000-00006, PMID: 11739064
Oltedal L, Bartsch H, Sørhaug OJ, Kessler U, Abbott C, Dols A, Stek ML, Ersland L, Emsell L, van Eijndhoven P,
Argyelan M, Tendolkar I, Nordanskog P, Hamilton P, Jorgensen MB, Sommer IE, Heringa SM, Draganski B,
Redlich R, Dannlowski U, et al. 2017. The global ECT-MRI research collaboration (GEMRIC): Establishing a
multi-site investigation of the neural mechanisms underlying response to electroconvulsive therapy.
NeuroImage: Clinical 14:422–432. DOI: https://doi.org/10.1016/j.nicl.2017.02.009, PMID: 28275543
Oltedal L, Narr KL, Abbott C, Anand A, Argyelan M, Bartsch H, Dannlowski U, Dols A, van Eijndhoven P, Emsell
L, Erchinger VJ, Espinoza R, Hahn T, Hanson LG, Hellemann G, Jorgensen MB, Kessler U, Oudega ML, Paulson
OB, Redlich R, et al. 2018. Volume of the human Hippocampus and clinical response following
electroconvulsive therapy. Biological Psychiatry 84:574–581. DOI: https://doi.org/10.1016/j.biopsych.2018.05.
017, PMID: 30006199
Ousdal OT, Argyelan M, Narr KL, Abbott C, Wade B, Vandenbulcke M, Urretavizcaya M, Tendolkar I, Takamiya
A, Stek ML, Soriano-Mas C, Redlich R, Paulson OB, Oudega ML, Opel N, Nordanskog P, Kishimoto T, Kampe
R, Jorgensen A, Hanson LG, et al. 2019. Brain changes induced by electroconvulsive therapy are broadly
distributed. Biological Psychiatry. DOI: https://doi.org/10.1016/j.biopsych.2019.07.010, PMID: 31561859
Perera TD, Coplan JD, Lisanby SH, Lipira CM, Arif M, Carpio C, Spitzer G, Santarelli L, Scharf B, Hen R, Rosoklija
G, Sackeim HA, Dwork AJ. 2007. Antidepressant-induced neurogenesis in the Hippocampus of adult nonhuman
primates. Journal of Neuroscience 27:4894–4901. DOI: https://doi.org/10.1523/JNEUROSCI.0237-07.2007,
PMID: 17475797
Argyelan et al. eLife 2019;8:e49115. DOI: https://doi.org/10.7554/eLife.49115 19 of 20
Research article Human Biology and Medicine
Pirnia T, Joshi SH, Leaver AM, Vasavada M, Njau S, Woods RP, Espinoza R, Narr KL. 2016. Electroconvulsive
therapy and structural neuroplasticity in neocortical, limbic and paralimbic cortex. Translational Psychiatry 6:
e832. DOI: https://doi.org/10.1038/tp.2016.102
R Development Core Team. 2013. R: A language and environment for statistical computing. Vienna, Austria: R
Foundation for Statistical Computing. http://www.r-project.org
Regenold WT, Noorani RJ, Piez D, Patel P. 2015. Nonconvulsive Electrotherapy for Treatment Resistant Unipolar
and Bipolar Major Depressive Disorder: A Proof-of-concept Trial. Brain Stimulation 8:855–861. DOI: https://doi.
org/10.1016/j.brs.2015.06.011
Roddy DW, Farrell C, Doolin K, Roman E, Tozzi L, Frodl T, O’Keane V, O’Hanlon E. 2019. The Hippocampus in
Depression: More Than the Sum of Its Parts? Advanced Hippocampal Substructure Segmentation in
Depression. Biological Psychiatry 85:487–497. DOI: https://doi.org/10.1016/j.biopsych.2018.08.021
Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J. 2000. A
prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at
different stimulus intensities. Archives of General Psychiatry 57:425–434. DOI: https://doi.org/10.1001/
archpsyc.57.5.425, PMID: 10807482
Sackeim HA. 2015. Is the seizure an unnecessary component of electroconvulsive therapy? A startling possibility.
Brain Stimulation 8:851–854. DOI: https://doi.org/10.1016/j.brs.2015.07.026, PMID: 26358486
Sartorius A, Demirakca T, Bo¨hringer A, Clemm von Hohenberg C, Aksay SS, Bumb JM, Kranaster L, Ende G.
2016. Electroconvulsive therapy increases temporal gray matter volume and cortical thickness. European
Neuropsychopharmacology 26:506–517. DOI: https://doi.org/10.1016/j.euroneuro.2015.12.036, PMID: 267
92445
Schulte E, Davison D, Dye T, Dominik C. 2012. A Multi-Language computing environment for literate
programming and reproducible research. Journal of Statistical Software 46:1–24. DOI: https://doi.org/10.
18637/jss.v046.i03
Scott BW, Wojtowicz JM, Burnham WM. 2000. Neurogenesis in the dentate gyrus of the rat following
electroconvulsive shock seizures. Experimental Neurology 165:231–236. DOI: https://doi.org/10.1006/exnr.
2000.7458, PMID: 10993683
Segi-Nishida E. 2011. Exploration of new molecular mechanisms for antidepressant actions of electroconvulsive
seizure. Biological & Pharmaceutical Bulletin 34:939–944. DOI: https://doi.org/10.1248/bpb.34.939,
PMID: 21719995
Smitha JS, Roopa R, Khaleel N, Kutty BM, Andrade C. 2014. Images in electroconvulsive therapy:
electroconvulsive shocks dose-dependently increase dendritic arborization in the CA1 region of the rat
Hippocampus. The Journal of ECT 30:191–192. DOI: https://doi.org/10.1097/YCT.0000000000000077,
PMID: 24901430
Sorrells SF, Paredes MF, Cebrian-Silla A, Sandoval K, Qi D, Kelley KW, James D, Mayer S, Chang J, Auguste KI,
Chang EF, Gutierrez AJ, Kriegstein AR, Mathern GW, Oldham MC, Huang EJ, Garcia-Verdugo JM, Yang Z,
Alvarez-Buylla A. 2018. Human hippocampal neurogenesis drops sharply in children to undetectable levels in
adults. Nature 555:377–381. DOI: https://doi.org/10.1038/nature25975, PMID: 29513649
Swartz CM. 2006. Electroconvulsive therapy stimulus dose expressed as volume of seizure foci. The Journal of
ECT 22:54–58. DOI: https://doi.org/10.1097/00124509-200603000-00012
Swartz CM, Krohmer R, Michael N. 2012. ECT stimulus dose dependence on current separately from charge.
Psychiatry Research 198:164–165. DOI: https://doi.org/10.1016/j.psychres.2011.12.046, PMID: 22417930
Takamiya A, Chung JK, Liang KC, Graff-Guerrero A, Mimura M, Kishimoto T. 2018. Effect of electroconvulsive
therapy on hippocampal and amygdala volumes: systematic review and meta-analysis. The British Journal of
Psychiatry 212:19–26. DOI: https://doi.org/10.1192/bjp.2017.11, PMID: 29433612
Takamiya A, Plitman E, Chung JK, Chakravarty M, Graff-Guerrero A, Mimura M, Kishimoto T. 2019. Acute and
long-term effects of electroconvulsive therapy on human dentate gyrus. Neuropsychopharmacology 44:1805–
1811. DOI: https://doi.org/10.1038/s41386-019-0312-0, PMID: 30622299
Tang A, Thickbroom G, Rodger J. 2017. Repetitive transcranial magnetic stimulation of the brain: mechanisms
from animal and experimental models. The Neuroscientist : A Review Journal Bringing Neurobiology,
Neurology and Psychiatry 23:82–94. DOI: https://doi.org/10.1177/1073858415618897, PMID: 26643579
UK ECT Review Group. 2003. Efficacy and safety of electroconvulsive therapy in depressive disorders: a
systematic review and meta-analysis. The Lancet 361:799–808. DOI: https://doi.org/10.1016/S0140-6736(03)
12705-5, PMID: 12642045
van Buel EM, Patas K, Peters M, Bosker FJ, Eisel UL, Klein HC. 2015. Immune and neurotrophin stimulation by
electroconvulsive therapy: is some inflammation needed after all? Translational Psychiatry 5:e609. DOI: https://
doi.org/10.1038/tp.2015.100, PMID: 26218851
Vickers AJ. 2001. The use of percentage change from baseline as an outcome in a controlled trial is statistically
inefficient: a simulation study. BMC Medical Research Methodology 1:6. DOI: https://doi.org/10.1186/1471-
2288-1-6, PMID: 11459516
Wennstro¨m M, Hellsten J, Tingstro¨m A. 2004. Electroconvulsive seizures induce proliferation of NG2-expressing
glial cells in adult rat amygdala. Biological Psychiatry 55:464–471. DOI: https://doi.org/10.1016/j.biopsych.
2003.11.011, PMID: 15023573
Yrondi A, Sporer M, Pe´ran P, Schmitt L, Arbus C, Sauvaget A. 2018. Electroconvulsive therapy, depression, the
immune system and inflammation: A systematic review. Brain Stimulation 11:29–51. DOI: https://doi.org/10.
1016/j.brs.2017.10.013
Argyelan et al. eLife 2019;8:e49115. DOI: https://doi.org/10.7554/eLife.49115 20 of 20
Research article Human Biology and Medicine
